Suppr超能文献

羟乙基淀粉350/0.60在血容量正常男性体内的尿排泄动力学

Urinary excretion kinetics of hydroxyethyl starch 350/0.60 in normovolaemic man.

作者信息

Mishler J M, Ricketts C R, Parkhouse E J

出版信息

J Clin Pathol. 1981 Apr;34(4):361-5. doi: 10.1136/jcp.34.4.361.

Abstract

Rates of urinary excretion concomitant with the molecular size distribution of filtered polymer fragments were determined in five normovolaemic men dosed with 30 g/m2 BSA of a species of HES (HES 350/0.60) possessing a M-W of 350 000 combined with an MS of 0.60. Approximately 13% of the total injected dose of HES 350/0.60 was excreted in urine 1 hr after dosing, and 45% by 72 hours. Gel filtration of Sepharose CL-4B revealed that aliquots of urine collected 1 hour after injection contained polymer fragments of HES 350/0.60 with values of Kav ranging between 0.88 and 0.84, and possessed a Stokes radius (r = 32A) similar to that of Dextran 20 (M-W 22 700). Polymer fragments of HES 350/0.60 excreted 6 to 48 hours after dosing, however, possessed a Kav ranging between 0.78 and 0.73 with a Stokes radius (r = 45A) similar to that of Dextran 40 (M-W 41 000). All filtered polymer fragments were less polydisperse relative to both the injection solution (Kav 0.60) and residual material recovered from blood immediately after injection (Kav 0.72). These data support the hypothesis that the excretion of HES 350/0.60 occurs in two distinct phases: a rapid phase of elimination dependent on the M-n of the injected solution, and a slower phase dependent on the MS (degree of resistance to alpha-amylase attack). This study, in conjunction with our previous investigation of the changes in circulating HES 350/0.60, define the basic differences between clearance and excretion of the dextrans and of the rapidly degraded species of HES. These data are relevant to the utilisation of HES 350/0.60 during centrifugal leucapheresis.

摘要

在五名血容量正常的男性中,测定了给予30 g/m²体表面积的一种平均分子量为350000且摩尔取代度为0.60的羟乙基淀粉(HES 350/0.60)后,尿排泄率与滤过聚合物片段的分子大小分布情况。给药后1小时,约13%的HES 350/0.60总注射剂量经尿液排出,至72小时时为45%。用琼脂糖CL-4B进行凝胶过滤显示,注射后1小时收集的尿液等分试样中含有HES 350/0.60的聚合物片段,其分配系数(Kav)值在0.88至0.84之间,斯托克斯半径(r = 32Å)与葡聚糖20(平均分子量22700)相似。然而,给药后6至48小时排出的HES 350/0.60聚合物片段的Kav在0.78至0.73之间,斯托克斯半径(r = 45Å)与葡聚糖40(平均分子量41000)相似。相对于注射溶液(Kav 0.60)和注射后立即从血液中回收的残留物质(Kav 0.72),所有滤过的聚合物片段的多分散性均较低。这些数据支持以下假设:HES 350/0.60的排泄分为两个不同阶段:一个快速消除阶段,取决于注射溶液的数均分子量;一个较慢阶段,取决于摩尔取代度(对α-淀粉酶攻击的抗性程度)。本研究与我们之前对循环中HES 350/0.60变化的调查一起,明确了葡聚糖和快速降解的HES物种在清除和排泄方面的基本差异。这些数据与在离心白细胞分离术中使用HES 350/0.60相关。

相似文献

本文引用的文献

6
A clinical physiologic study of hydroxyethyl starch.
Surg Gynecol Obstet. 1970 Aug;131(2):255-67.
8
Plasma clearance and renal excretion of erythrocyte cryoprotectant hydroxyethylated amylopectin.
Br J Haematol. 1978 Oct;40(2):231-7. doi: 10.1111/j.1365-2141.1978.tb03660.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验